drugset / Trial / NCT03804645
A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
AZD9977 is an oral, selective mineralocorticoid receptor (MR) modulator. AZD9977 is a partial antagonist and partial agonist in reporter gene assays and has a different interaction pattern with the MR compared to eplerenone. This study will assess the pharmacokinetics (PK) of four different Formulations of AZD9977 (Part A) and influence of food and lower dose of a selected formulation (Part B) in healthy male subjects.
Timeline
- Start
- 2019-02-05
- Primary completion
- 2019-04-16
- Completion
- 2019-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | balcinrenone | Small molecule | 50 mg | Oral |
| Subject | balcinrenone | Small molecule | 300 mg | Oral |